We have released our Quarterly Activity Report and Appendix 4C for the period ending on 31 March 2022. Read the full announcements here:
https://t.co/ObUMSDIb8j $IBX #ASX
$IBX 6c 👀
Finally we get a trial update and it looks sound to me.
5 patients have been completed the study with NO safety issues.
The study showed the imaging agent has reached the lymph nodes.
$IBX no point panic selling now. We know mid year we will hear something. If the SP keeps going down, good time for new investors / top up time. Tech is the same!
@Dimitrios_1963 @afroeeee @AsxIbx It will reach a point where new/fresh investors will take positions as it’s now too heavily discounted IMO. Anyone selling here likely had the chance at 15c+ to sell and chose to hold (for the tech which hasn’t changed, only delayed). Psychology is at the low on this stock now.